THIP KPI 2024

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 42 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0102 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆï÷ć Aspirin õć÷Ĕî 24 ßĆęüēöÜđöČęĂöćëċÜ ēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of patient receiving Aspirin within 24 hours of arrival îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆï Aspirin õć÷Ĕî 24 ßĆęüēöÜđöČęĂöćëċÜ ēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚ ĒúąĕéšøĆï Aspirin ĔîÖćøøĆÖþć ēé÷îĆïøą÷ąđüúćêĆĚÜĒêŠöĊĂćÖćøĒúąöćêøüÝøĆÖþćìĊę ER/OPD ĒúąøĆïĕüšĔîēøÜó÷ćïćú ÝîëċÜøą÷ąđüúćìĊęñĎšðśü÷ĕéšøĆï÷ć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîÙüćöđĀöćąÿö×ĂÜÖćøéĒúø Ď ĆÖþćÖúöñčŠ Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðü÷õćüąĀ ś ĆüĔÝ×ćéđúĂéđÞ Č Ċ÷ïóúĆîìĕéĊę øšĆï Aspirin õć÷Ĕî 24 ßĆęüēöÜ đöČęĂöćëċÜ ēøÜó÷ćïćúĔîđéČĂîîîĆĚ êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęøĆïđךćøĆÖþćĔîēøÜó÷ćïćú ĔîđéČĂî đéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * U.S.A. National Median : 84 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I ,ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 (Thai acute coronary syndrome guidelines 2020) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0102

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 43 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0103 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęĕéšøĆïÖćøÿĆęÜ÷ć Aspirin đöČęĂÝĈĀîŠć÷ĂĂÖ ÝćÖēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute Coronary Syndrome: Percent of Aspirin prescribed at discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęĕéšøĆïÖćøÿĆęÜ÷ć Aspirin đöČęĂÝĈĀîŠć÷ĂĂÖÝćÖ ēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš ÷ćîĊĚĒúąöĊÖćøÿĆęÜĔĀ÷ćš Aspirin đöČęĂÝĈĀîŠć÷ñĎšðśü÷ĂĂÖÝćÖēøÜó÷ćïćú ēé÷îĆïđÞóćąÖćø ÝĈĀîŠć÷öĊßĊüĉêéšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîÙüćöđĀöćąÿö×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðü÷õćüąĀ ś ĆüĔÝ×ćéđúĂéđÞ Č Ċ÷ïóúĆî (ACS) ìĕéĊę øšĆïÖćøÿĆęÜ÷ć AspirinđöČęĂÝĈĀîŠć÷ ĂĂÖÝćÖēøÜó÷ćïćúĔîđéČĂîîîĆĚ êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìČęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ēé÷îĆïđÞóćąÖćøÝĈĀîŠć÷öĊßĊüĉêéü÷ÿëćîąÖćøĂî š čâćêĔĀšÖúĆïïšćî ĔîđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * U.S.A. National Median : 85 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I, ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0103

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 44 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0104 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęöĊLVSD ĒúąĕéøšĆï÷ć ACE inhibitors ĀøČĂ ARBs ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of ACE inhibitors or ARBs received for patient who have LVSD îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęöĊLVSD Āöć÷ëċÜ ñĎšðśü÷ ACS ìĊęĕéšøĆïÖćø êøüÝéšü÷ÙúČęîđÿĊ÷Ü ultrasound ĒúšüóïüŠćöĊ LVSD 3. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕéšøĆï÷ć ACE inhibitors ĀøČĂ ARBs Āöć÷ëċÜ ñĎšðśü÷ ACS ìĊęĕöŠöĊךĂĀšćö ĀøČĂךĂÝĈÖĆé (ñĎšðśü÷Ēóš÷ć, ÙüćöéĆîēúĀĉêêęĈÖüŠć 100/60 mmHg) ×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï÷ć ACE inhibitors ĀøČĂ ARBs ĔîÖćøøĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîÙüćöđĀöćąÿö×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìöĊę ĊLVSD ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúĂéđÞ Č Ċ÷ïóúĆî (ACS) ìĊęöĊLVSD ĒúąĕéšøĆï÷ć ACE inhibitors ĀøČĂ ARB ìĆĚÜĀöéĔîđéČĂîîîĆĚ êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęöĊLVSD ìĆĚÜĀöé ĔîđéČĂî đéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference NQF, ÿðÿß., ĒîüìćÜđüßðäĉïĆêÖćøé ĉ ĎĒúøĆÖþćñðĎš śü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): (1) ðøĆïîĉ÷ćöēé÷êĆéÙĈüŠć “ēøÜó÷ćïćúêšĂÜöĊđÙøČęĂÜ Ultrasound” ĂĂÖ àċęÜĀöć÷ëċÜ ēøÜó÷ćïćúĂćÝĕöŠöđÙø Ċ ČęĂÜ Ultrasound ĒêŠöĊüĉíĊÖćøìĊęÝą ìĈĔĀšñĎšðśü÷ĕéšøĆïÖćøêøüÝéšü÷đÙøČęĂÜ Ultrasound G DH0104

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 45 ðøĆïðøčÜÙøĆĚÜìĊę2 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 46 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0105 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęÿĎïïĀøč ĊęĒúąĕéšøĆïÖćøĒîąîĈĔĀšÜéïčĀøĊę øąĀüŠćÜÖćøĂ÷ēøÜó÷ćïćú ĎŠ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of smoking cessation advice given îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęÿĎïïčĀøĊęĒúąĕéšøĆïÖćøĒîąîĈĔĀšÜéïčĀøĊę øąĀüŠćÜÖćøĂ÷ĎŠēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ ACS ìĊęöĊðøąüĆêĉÿĎïïčĀøĊęõć÷Ĕî 1 ðŘÖŠĂîĕéøšĆï ÖćøêøüÝøĆÖþćĒúąøĆïĕüšĔîēøÜó÷ćïćú ĕéšøĆïÙĈĒîąîĈ/Counseling ĔĀšÙüćöøĎšÙüćö đךćĔÝđÖĊę÷üÖĆïñúÖøąìï×ĂÜïčĀøĊęêŠĂõćüą×ĂÜēøÙìĊęđðŨî đóČęĂĔĀšñĎšðśü÷ÜéïčĀøĊęøąĀüŠćÜÖćø Ă÷ĎŠēøÜó÷ćïćú ĒúąĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊęêŠĂĕð üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîÙüćöđĀöćąÿö×ĂÜÖćøéĒúø Ď ĆÖþćĔîöĉêĉÖćøÿŠÜđÿøĉöÿč×õćóÖúčŠöñĎšðśü÷õćüąĀĆüĔÝ ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìÿĊę ĎïïĀøč ĊęĒúąìĕéĊę šøĆïÖćøĒîąîĈĔĀš ÜéïčĀøĊęøąĀüŠćÜÖćøĂ÷ĎŠēøÜó÷ćïćúĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęÿĎïïĀøč ĊęìÜĀöéì ĆĚ ĊęøĆïĕüšĔî ēøÜó÷ćïćú ĔîđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * U.S.A. 2005 = 92.1 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0105

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 47 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0106 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęĕéšøĆï÷ć Beta-blocker øąĀüŠćÜøĆïĕüšøĆÖþć ĔîēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of Beta-blocker receiving during hospital admitted îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕéšøĆï Beta-blocker øąĀüŠćÜøĆïĕüšøĆÖþć ĔîēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ ACS ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚĒúą ĕéšøĆï÷ć Betablocker ĔîøąĀüŠćÜøĆïĕüšøĆÖþćĔîēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî (ACS) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ć Ēúą ĕéšøĆï Beta-blocker øąĀüŠćÜøĆïĕüšøĆÖþćĔîēøÜó÷ćïćúĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚìĊęđךć øĆïÖćøøĆÖþćĔîēøÜó÷ćïćúĔîđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I, ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): (1) ðøĆïßČęĂêĆüßĊĚüĆéĒúąîĉ÷ćö ēé÷êĆéÙĈüŠć “õć÷Ĕî 24 ßĆęüēöÜđöČęĂöćëċÜēøÜó÷ćïćú” ĂĂÖ ēé÷Ēìîéšü÷ÙĈüŠć “øąĀüŠćÜøĆïĕüšøĆÖþćĔîēøÜó÷ćïćú” ĔĀšÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïêĆĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0106

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 48 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0107 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęĕéšøĆïÖćøÿĆęÜ÷ć Beta-blocker đöČęĂÝĈĀîŠć÷ ÝćÖēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of Beta-blocker prescribed at discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕéšøĆï÷ć Beta-blocker đöČęĂÝĈĀîŠć÷ÝćÖ ēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ ACS ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚĒúą öĊÖćøÿĆęÜĔĀš÷ć Betablocker đöČęĂÝĈĀîŠć÷ñĎšðśü÷ĂĂÖÝćÖēøÜó÷ćïćúēé÷ÖćøĂîčâćêĔĀšÖúĆïïšćî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîÙüćöđĀöćąÿö×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ć ìĊę ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Ēúą ĕéšøï÷ć Ć Beta-blocker đöČęĂÝĈĀîŠć÷ ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚìĊę ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćúēé÷îĆïđÞóćąÖćøÝĈĀîŠć÷öĊßĊüĉêéšü÷ÿëćîąÖćøĂîâćêĔĀ č š ÖúĆïïšćî ĔîđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I ,ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüđüßðäĉïĆêĉÖćøéĎĒúøĆÖþć ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč G DH0107

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 49 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0108 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćđÞúĊę÷ìñĊę Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęĕéøšĆïÖćøìĈ EKG đöČęĂöćëċÜ ēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Average door to EKG time îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. øą÷ąđüúćìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ĕéšøĆïÖćøìĈ EKG đöČęĂöćëċÜ ēøÜó÷ćïćú Āöć÷ëċÜ ßŠüÜđüúćîĆïêĆĚÜĒêŠñĎšðśü÷ ACS öćëċÜēøÜó÷ćïćú (ĔîìčÖ OPD, ER) ÝîëċÜĕéšøĆïÖćøìĈ EKG ÙøĆĚÜĒøÖ×ĂÜÖćøêøüÝøĆÖþć ēé÷öĊĀîŠü÷îĆïđðŨîøć÷îćìĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖøąïüîÖćøðøąđöĉîÖúöñčŠ Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ÿĎêøĔîÖćøÙĈîüè a/b ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = øą÷ąđüúćøüö (îćìĊ) ìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ĕéøšĆïÖćøìĈ EKG đöČęĂöćëċÜēøÜó÷ćïćúìčÖøć÷ ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüî (Ùî) ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęöćēøÜó÷ćïćú ĒúąĕéšøĆï ÖćøìĈ EKG ìĆĚÜĀöé ĔîđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé îćìĊ Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0108

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 50 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0109 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćđÞúĊę÷ìñĊę Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî öćëċÜēøÜó÷ćïćúÝîĕéšøĆïÖćøÿŠÜêŠĂ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Average door to refer time îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. øą÷ąđüúćìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) öćëċÜēøÜó÷ćïćúÝîĕéšøĆïÖćø ÿŠÜêŠĂ Āöć÷ëċÜ ßŠüÜđüúćîĆïêĆĚÜĒêŠñĎšðśü÷ ACS öćëċÜēøÜó÷ćïćú (ĔîìčÖ OPD, ER) ÝîëċÜ ĕéšøĆïÖćøÿŠÜêŠĂ ēé÷öĊĀîŠü÷îĆïđðŨîîćìĊ 3. ÖøąïüîÖćøÿŠÜêŠĂñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) êšĂÜĕöŠĂ÷ĎŠõć÷Ĕêš×šĂÝĈÖĆé đøČęĂÜ ēøÜó÷ćïćúðúć÷ìćÜ/ēøÜó÷ćïćúñĎšøĆïÿŠÜêŠĂ (refer) ÖĈĀîéĔĀšöĊÖćøêøüÝìćÜ ĀšĂÜðäĉïĆêĉÖćøĔĀšÙøïÖŠĂîÿŠÜêŠĂ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøïøĉĀćøÝĆéÖćøĒúąÖøąïüîÖćøðøąđöĉîÖúčŠöñĎšðśü÷õćüąĀĆüĔÝ×ćé đúČĂéđÞ÷ïóú Ċ Ćî (ACS) ÿĎêøĔîÖćøÙĈîüè a/b ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = øą÷ąđüúćøüö (îćìĊ) ìñĊę Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) öćëċÜēøÜó÷ćïćú ÝîĕéøšĆïÖćøÿŠÜêŠĂìčÖøć÷ ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüî (Ùî) ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî (ACS) ìĊęöćēøÜó÷ćïćú ĒúąĕéøšĆï ÖćøÿŠÜêŠĂìĆĚÜĀöé ĔîđéČĂîđéĊ÷üÖîĆ øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé îćìĊ Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüđüßðäĉïĆêĉÖćøéĎĒúøĆÖþć ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč G DH0109

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 51 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0110 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĕéĊę šøĆï Primary Percutaneous Coronary Intervention (PPCI) õć÷Ĕî 120 îćìĊĀøČĂ Fibrinolytic Agent õć÷Ĕî 30 îćìĊđöČęĂĒøÖøĆï ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome (STEMI): Percent of Primary Percutaneous Coronary Intervention (PCI) given within 120 minutes or received Fibrinolytic agent within 30 minutes of arrival îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ÷Ö×ċĚî (STEMI) Āöć÷ëċÜ ñĎšðśü÷ Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊ principal diagnosis (Pdx) đðŨîõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) àċęÜêšĂÜĔĀš÷ćúąúć÷úĉęöđúČĂé (Fibrinolytic Agent) Ēúą/ĀøČĂ Öćø×÷ć÷ĀúĂé đúČĂéĀĆüĔÝ (PCI: Percutaneous Coronary Intervention) ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîñĎšðśü÷ STEMI ìĊęĕöŠöĊךĂÝĈÖĆé×ĂÜÖćøìĈ PPCI ĀøČĂĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš Thrombolytic agent ĔîÖćøøĆÖþć 3. ÖćøĕéšøĆï PPCI õć÷Ĕî 120 îćìĊĀøČĂ Fibrinolytic agent õć÷Ĕî 30 îćìĊîĆïêĆĚÜĒêŠ øą÷ąđüúćìĊęñĎšðśü÷ĕéšøĆïÖćøêøüÝøĆÖþćìĊę ER/OPD ĒúąøĆïĕüšĔîēøÜó÷ćïćú ÝîëċÜđüúćìĊę ñĎšðśü÷ĕéšìĈ PPCI ĀøČĂĕéšøĆï÷ć Fibrinolytic agent üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖøąïüîÖćøéĎĒúøĆÖþćÖúöñčŠ Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕöŠöĊ ךĂÝĈÖĆé×ĂÜÖćøìĈ PPCI ĀøČĂĕööŠ ĊךĂĀšćö×ĂÜÖćøĔĀšThrombolytic agent ĔîÖćøøĆÖþć ìĊęøĆïĕüšĔîēøÜó÷ćïćú ìĊęĕéšøĆï PPCI õć÷Ĕî 120 îćìĊĀøČĂ Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂĒøÖøĆï ĔîߊüÜĕêøöćÿ (3 đéČĂî) îĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕöŠöĊ ךĂÝĈÖĆé×ĂÜÖćøìĈ PPCI ĀøČĂĕööŠ ĊךĂĀšćö×ĂÜÖćøĔĀšThrombolytic agent ĔîÖćøøĆÖþć ìĊęøĆïĕüšĔîēøÜó÷ćïćúìĆĚÜĀöé ĔîĕêøöćÿđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3 Ēúą procedure = 00.66, 00.40-00.48, 36.01-36.02, 36.05-36.07, 36.09, 99.10, 37.68 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî ĀøČĂ ìčÖĕêøöćÿ (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * DH0110

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 52 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿí., ÿðÿß./ 1) Krumholz et al. ACC/AHA 2008 Performance Measures for Adults with ST-Elevation And Non-ST-Elevation Myocardial Infarction. J Am Coll Cardiol, 2008; 52: 2046-2099. 2) O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2559): (1) ðøĆïđðúĊę÷îßČęĂĒúąÙĈîĉ÷ćö×ĂÜêĆüßĊĚüĆéĔĀšöĊÙüćö ÙøĂïÙúčööćÖ×ċĚî ēé÷ÙĈîĉ÷ćöÙøĂïÙúčöìĆĚÜñĎšìĊęĕéšøĆï PCI õć÷Ĕî 90 îćìĊĀøČĂ Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂĒøÖøĆï ĂšćÜĂĉÜêćöĀúĆÖåćîüĉßćÖćø ēé÷ ךĂđÿîĂĒîą×ĂÜÖøöÖćøĒóì÷Ť ðøĆïðøčÜÙøĆĚÜìĊę2 (êčúćÙö 2564): ðøĆïđðú÷îøą÷ąđüúćÖćøĕé Ċę øšĆï PPCI ÝćÖ 90 îćìĊđðŨî øą÷ąđüúć 120 îćìĊĂšćÜĂĉÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñðĎš śü÷õćüąĀĆüĔÝ×ćé đúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč G

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 53 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0111 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of unplanned re-admission within 28 days after last discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî õć÷Ĕî 28 üĆî ēé÷ ĕöŠĕéšüćÜĒñî Āöć÷ëċÜ ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęøĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜ ÝĈĀîŠć÷ÝćÖēøÜó÷ćïćúõć÷Ĕî 28 üĆî éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status=improve) ÷Öđüšî ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕðøĆÖþćìĊęēøÜó÷ćïćú ĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćó×ĂÜÖøąïüîÖćøüćÜĒñîÝĈĀîŠć÷ĒúąÖćøéĎĒúøĆÖþćÖúöñčŠ Ďšðśü÷ ACS ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìöĊę ĊÖćøøĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜ ÝĈĀîŠć÷õć÷Ĕî 28 üĆî ēé÷ĕöĕéŠ šüćÜĒñî ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęÝĈĀîŠć÷éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆï ïšćî (Status=improve) ĔîđéČĂîÖŠĂîĀîšćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9, I22.1, I22.8, I22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒú øĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 Āöć÷đĀêč G DH0111

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 54 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0112 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Average length of stay îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×îċĚ (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Āöć÷ëċÜ ñúøüö×ĂÜ ÝĈîüîüĆîîĂîìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîîĂîóĆÖøĆÖþćêĆüĔîēøÜó÷ćïćúēé÷ îĆïêĆĚÜĒêŠüĆîìĊęøĆïĕüšÝîëċÜüĆîìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćúìčÖøć÷ìĊęÝĈĀîŠć÷ĔîđéČĂîîĆĚî Āćøéšü÷ÝĈîüîñĎšðü÷õćüąĀ ś ĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęÝĈĀîŠć÷ĔîđéČĂîîĆĚî 3. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ìĊęÝĈĀîŠć÷ĂĂÖÝćÖ ēøÜó÷ćïćú ìčÖÿëćîąÖćøÝĈĀîŠć÷ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøøĆÖþćñðĎš śü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúîĆ ÿĎêøĔîÖćøÙĈîüè (a/b) ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ñúøüöøą÷ąđüúćüĆîîĂî×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ ĆîìčÖøć÷ìĊęÝĈĀîć÷Ĕî Š đéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęÝĈĀîŠć÷ĔîđéČĂîîĆĚî (Ùî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé üĆî Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüđüßðäĉïĆêĉÖćøéĎĒúøĆÖþć ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč G DH0112

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 55 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0113 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕéšøĆï Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂöćëċÜēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome (STEMI) : Percent of time to Fibrinolytic administration agents within 30 minutes of arrival îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ÷Ö×ċĚî (STEMI) Āöć÷ëċÜ ñĎšðśü÷ Ăć÷č œ 18 ðŘìĊęöĊprincipal diagnosis (Pdx) đðŨîõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) àċęÜêšĂÜĔĀš÷ćúąúć÷úĉęöđúČĂé (Fibrinolytic agent) ēé÷öĊøĀĆÿ ēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕöŠöĊךà Āšćö×ĂÜÖćøĔĀšThrombolytic agent ĔîÖćøøĆÖþć 3. ÖćøĕéšøĆï Fibrinolytic agent õć÷Ĕî 30 îćìĊîĆïêĆĚÜĒêŠøą÷ąđüúćìĊęñĎšðśü÷ĕéšøĆïÖćø êøüÝøĆÖþćìĊę ER/OPD ĒúąøĆïĕüšĔîēøÜó÷ćïćú ÝîëċÜđüúćìĊęñĎšðśü÷ĕéšøĆï÷ć Fibrinolytic agent üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖøąïüîÖćøéĎĒúøĆÖþćÖúöñčŠ Ďšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕöŠöĊ ךĂĀšćö×ĂÜÖćøĔĀšThrombolytic agent ĔîÖćøøĆÖþć ìĊęøĆïĕüšĔîēøÜó÷ćïćú ìĊęĕéøšĆï÷ć Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂĒøÖøĆïĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕöŠöĊ ךĂĀšćö×ĂÜÖćøĔĀšThrombolytic agent ĔîÖćøøĆÖþć ìĊęøĆïĕüšĔîēøÜó÷ćïćúìĆĚÜĀöé Ĕî đéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 Ēúą Procedure 99.10 õć÷Ĕî 30 îćìĊ êĆüĀćø Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 Ēúą Procedure 99.10 ìĆĚÜĀöé ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * U.S.A. National Average : 38.6 (2005) üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I / 1) Krumholz et al. ACC/AHA 2008 Performance Measures for Adults with ST-Elevation And Non-ST-Elevation Myocardial Infarction. J Am Coll Cardiol, 2008; 52: 2046-2099. 2) O’Gara PT, Kushner FG, Ascheim DD, et al. G DH0113

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 56 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61(4): 485-510. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2559): ðøĆïđðú÷îß Ċę ČęĂĒúąÙĈîĉ÷ćö×ĂÜêüßĆ ĊĚüĆé ÝćÖ Thrombolytic Agents đðŨî Fibrinolytic Agents đóČęĂĔĀÿĂéÙú š ĂÜÖ š Ćï ACCF/AHA ðøĆïðøčÜÙøĆĚÜìĊę2 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüđüßðäĉïĆêĉÖćøéĎĒúøĆÖþć ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 57 ž¦³Á£š DH02 Coronary artery disease ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Coronary artery disease øĀĆÿêĆüßĊĚüĆé DH0201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ìĊęìĈ Coronary Artery Bypass Graft (CABG) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Coronary Artery Bypass Graft (CABG): Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ìĊęìĈ CABG Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂé ĀĆüĔÝàċęÜÝĈđðŨîêšĂÜĕéšøĆïÖćøêøüÝøĆÖþćéšü÷ÖćøìĈ CABG ÝćÖìčÖĀĂñĎšðśü÷Ĕî ēé÷öĊøĀĆÿ ēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ìĊęìĈ CABG Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ìĊęĕéšøĆï ÖćøñŠćêĆéìĈìćÜđïĊę÷ÜĀúĂéđúČĂéĀĆüĔÝ (Coronary Artery Bypass Graft: CABG) 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷Ĕî ĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ìĊęìĈ CABG ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ìĊęìĈ CABG Ēúüđÿš Ċ÷ßĊüĉê êĆüĀćø b = ÝĈîüîñĎšðśü÷ìĊęìĈ CABG ĒúüÝĈĀî š Šć÷ìĆĚÜĀöéĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 êĆüĀćø Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * UK 1-3 % üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DH0201

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 58 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Coronary artery disease øĀĆÿêĆüßĊĚüĆé DH0202 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøĕéšøĆï÷ćðäĉßĊüîąĒïïðŜĂÜÖĆîĔîÖćøñŠćêĆé Coronary Artery Bypass Graft (CABG) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Coronary Artery Bypass Graft (CABG): Percent of patient who received antibiotic prophylaxis îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ìĊęìĈ CABG Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéĀĆüĔÝàċęÜ ÝĈđðŨîêšĂÜĕéšøĆïÖćøêøüÝøĆÖþćéšü÷ÖćøìĈ CABG ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆï÷ćðäĉßĊüîąĒïïðŜĂÜÖĆîĔîÖćøñŠćêĆé CABG Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĕéšøĆï÷ć ðäĉßĊüîąĔîߊüÜøą÷ąđüúćõć÷Ĕî 1 ßĆęüēöÜÖŠĂîúÜöĊéñŠćêĆé (ÖøèĊđðŨîÖćøĔĀš÷ćĒïï IV drip ĔĀšđøĉęöîĆïđüúćđöČęĂ drip ÷ćĀöé) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúñĎšðü÷ñ ś ŠćêéĆ CABG ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêĆé CABG ìĊęĕéšøĆï prophylactic antibiotic õć÷Ĕî 1 ßĆęüēöÜ ÖŠĂîúÜöĊéñŠćêĆéĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéĆ CABG ìĆĚÜĀöéĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 êĆüĀćø Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I 2012http://www.ashp.org/surgical-guidelines http://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč ĂĆêøćÖćøêĉéđßČĚĂ 0.23- 5.67 G DH0202

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 59 ĀöüéêĆüßĊĚüĆé Cardiovascular Disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Coronary artery disease øĀĆÿêĆüßĊĚüĆé DH0203 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêéđß ĉ ČĚĂĒñúñŠćêĆé Coronary Artery Bypass Graft (CABG) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Coronary Artery Bypass Graft (CABG): Percent of surgical site Infection îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ìĊęìĈ CABG Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂé ĀĆüĔÝ àċęÜÝĈđðŨîêšĂÜĕéšøĆïÖćøêøüÝøĆÖþćéšü÷ÖćøìĈ CABG ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøêĉéđßČĚĂĒñúñŠćêĆé CABG Āöć÷ëċÜ đÞóćąÖćøêĉéđßČĚĂÙøĆĚÜĒøÖ×ĂÜĒñúñŠćêĆé CABG õć÷ĔîߊüÜøą÷ąđüúć 30 üĆîĀúĆÜÖćøñŠćêĆé üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤ×ĂÜÖćøéĎĒúøĆÖþćñĎšðśü÷ìĊęöĊÖćøñŠćêĆé CABG ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøêĉéđßČĚĂĒñúñŠćêĆé CABG ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéĆ CABG ìĆĚÜĀöé ĔîđéČĂîđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.19 Ēúą öĊÖćøêéđß ĉ ČĚĂ êĆüĀćø Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.19 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I Agency for Healthcare Research and Quality (AHRQ), 2012 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): (1) ðøĆïÝĈîüîüĆîêĉéêćöĒñúÝćÖ 28 üĆîđðŨî 30 üĆî êćö CDC Definition of HAI Surveillance Ē÷Öøą÷ąđüúćÖćøêéêćöĂĂÖêćöÙüćöú ĉ ċÖ ×ĂÜÖćøêĉéđßČĚĂ ëšćđðŨî Superficial SSI Ýąêćö 30 üĆî ëšćđðŨî Deep SSI Ēúą organ/space SSI Ýąêćö 90 üĆî Āöć÷đĀêč G DH0203

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 60 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Coronary artery disease øĀĆÿêĆüßĊĚüĆé DH0204 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿ÷ßĊ Ċüĉê×ĂÜñĎšðśü÷ìĊęìĈ CABG õć÷Ĕî 30 üĆîĀúĆÜøĆïÖćøøĆÖþćĒïïñĎšðśü÷ĔîüĆîĒøÖ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Coronary Artery Bypass Graft (CABG): percent of 30 - day hospital mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1) ñĎšðśü÷ìĊęìĈ CABG Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊPrinciple diagnosis (Pdx) đðŨîēøÙĀúĂé đúČĂéĀĆüĔÝàċęÜÝĈđðŨîêšĂÜĕéšøĆïÖćøêøüÝøĆÖþćéšü÷ÖćøñŠćêĆéìĈìćÜđïĊę÷ÜĀúĂéđúČĂé ĀĆüĔÝ (Coronary Artery Bypass Graft: CABG) ÝćÖìčÖĀĂñĎšðśü÷ ēé÷đðŨîÖćø admit ÙøĆĚÜĒøÖĀúĆÜìĈĀĆêëÖćø ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2) ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ìĊęìĈ CABG õć÷Ĕî 30 üĆîĀúĆÜđךćøĆïÖćøøĆÖþćĒïïñĎšðśü÷Ĕî Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ìĊęĕéšøĆïÖćøñŠćêĆéìĈìćÜđïĊę÷ÜĀúĂéđúČĂé ĀĆüĔÝ (CABG) õć÷Ĕîøą÷ąđüúć 30 üĆî ìĆĚÜ×èąøĆïÖćøøĆÖþćĔîēøÜó÷ćïćúĒúą ĀúĆÜÝćÖÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú îĆïÝćÖüĆîìĊęđךćøĆïÖćøøĆÖþćĒïïñĎšðśü÷ĔîüĆîĒøÖ ÷ÖđüšîđðŨîÖćøđÿĊ÷ßĊüĉêÝćÖÿćđĀêčìĊęđÖĉéÝćÖĂčïĆêĉđĀêč üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖćøøĆÖþćñĎšðü÷ĕé ś øšĆïÖćøñŠćêéìĈìćÜđï Ć Ċę÷ÜĀúĂéđúČĂéĀĆüĔÝ (CABG) ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ìĊęìĈ CABG ìĊęđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêčõć÷Ĕîøą÷ąđüúć 30 üĆî ìĆĚÜ×èąøĆïÖćøøĆÖþćĔîēøÜó÷ćïćúĒúąĀúĆÜÝćÖÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú (÷ÖđüšîđðŨîÖćøđÿĊ÷ßĊüĉêÝćÖÿćđĀêčìĊęđÖĉéÝćÖĂčïĆêĉđĀêč) îĆïÝćÖüĆîìĊęđךćøĆïÖćøøĆÖþć ĒïïñĎšðśü÷ĔîüĆîĒøÖ ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ìĊęìĈ CABG ìĆĚÜĀöéĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 êĆüĀćø Procedure = 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, 36.18, 36.19 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî (êĆüßĊĚüĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąÖøøöÖćøóĆçîćøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2562 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč ēøÜó÷ćïćúđÖĘïךĂöĎúēé÷Öćøêĉéêćöÿëćîą×ĂÜñĎšðśü÷ĀúĆÜÝćÖüĆî Admit Ĕî ēøÜó÷ćïćú 30 üĆî éšü÷üĉíĊÖćø đߊî ÖćøêĉéêćöìćÜēìøýĆóìŤÖćøêøüÝÿĂïÖĆï åćîךĂöĎúìąđïĊ÷îøćþãøŤđðŨîêšî DH0204

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 61 ðøąđõì DH03 Heart Failure ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Heart failure øĀĆÿêĆüßĊĚüĆé DH0301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ĔîìĊęöĊĀĆüĔÝúšöđĀúüìđðĊę Ũî Heart Failure Reduced Ejection Fraction (HFREF) ĕéšøĆï÷ć Angiotensin II Converting Enzyme inhibitors (ACEIs) ĀøČĂ Angiotensin II Receptor Blockers (ARBs) ĀøČĂ Mineralocorticoid Receptor Antagonists (MRA) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Heart failure: Percent of patient with Heart Failure Reduced Ejection Fraction (HFREF) received Angiotensin II Converting Enzyme inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) or Mineralocorticoid Receptor Antagonists (MRA) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Heart failure Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøÖþćĔîēøÜó÷ćïćúîćî Ć êĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀĆüĔÝúšöđĀúü ēé÷öøĀĊ Ćÿ ēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷ Heart Failure Reduced Ejection Fraction (HFREF) Āöć÷ëċÜ ñĎšðśü÷ Heart failure ìĊęĕéšøĆïÖćøêøüÝéšü÷đÙøČęĂÜ echocardiogram ĒúšüóïüŠćöĊLVEF < 40% (ēøÜó÷ćïćúêšĂÜöĊđÙøČęĂÜ echocardiogram) 3. đðŨîñĎšðśü÷ HFREF ìĊęĕöŠöĊךĂĀšćö ĀøČĂךĂÝĈÖĆé (ñĎšðśü÷Ēó÷ćš , ñĎšðü÷ēøÙĀĂïĀ ś éČ, ñĎšðśü÷ìĊę öĊÖćøđêšîĀĆüĔÝßšćÖüŠć 50 ÙøĆĚÜêŠĂîćìĊ, ĒúąÙüćöéĆîēúĀĉê systolic êęĈÖüŠć 90 mmHg ×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï ACE inhibitors ĀøČĂ ARBs ĀøČĂ MRA ĔîÖćøøĆÖþć) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤĒúąðøąÿĉìíĉõćó×ĂÜÖøąïüîÖćøéĎĒúøĆÖþćñĎšðśü÷ Heart failure ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ HFREF ìĊęĕéøšĆï÷ć ACE inhibitors ĀøČĂ ARBs ĀøČĂ MRA ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ HFREF ìĊęĕöŠö×ĊšĂĀšćö ĀøČĂךĂÝĈÖĆéĔîÖćøĔĀ÷ćî š ĊĚĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I50 ìĊęĕéšøĆï÷ć ACE inhibitors ĀøČĂ ARBs ĀøČĂ MRA êĆüĀćø Pdx = I50 ìĊęĕöŠöĊךĂĀšćö ĀøČĂךĂÝĈÖĆéĔîÖćøĔĀš÷ćîĊĚ ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference 1) Bonow RO., Ganiats TG, Craig T, et al. Task Force on Performance Measures and the American Medical Association Report of the American College of Cardiology Foundation/American Heart Association ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: A Consortium for Performance Improvement. Circulaion. 2012; 125: 2382-2401. 2) McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the G DH0301

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 62 diagnosis and treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2559 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2559): (1) ðøĆïđðúĊę÷îßČęĂĒúąÙĈî÷ćö×ĂÜê ĉ ĆüßĊĚüĆé ÝćÖ LVSA đðŨî HFREF, ĒúąðøĆïđóöîĉę ĉ÷ćöÖćøĔĀš÷ćĔîÖúčŠö Mineralocorticoid Receptor Antagonists (MRA) ÝćÖÖćøìïìüîĀúĆÖåćîĂšćÜĂĉÜìćÜüĉßćÖćø đóČęĂĔĀšÿĂéÙúšĂÜÖĆï ACCF/AHA Āöć÷đĀêč

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 63 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Heart failure øĀĆÿêĆüßĊĚüĆé DH0302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ìĊęöĊõćüąĀĆüĔÝúöđĀúü š ìĊęÿïïĎ čĀøĊę ĕéšøĆïÖćøĒîąîĈĔĀšÜéïčĀøĊę øąĀüŠćÜÖćø Ă÷ĎŠēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Heart failure: Percent of smoking cessation advice given îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Heart failure Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćî êĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀĆüĔÝúšöđĀúü ēé÷öĊøĀĆÿēøÙ Ă÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĒîąĒîüĔĀšĂéĀøČĂđúĉÖïčĀøĊę Āöć÷ëċÜ ÖćøĔĀšÙĈĒîąîĈ/ÖćøðøċÖþć ĔĀšÙüćöøĎšÙüćö đךćĔÝđÖĊę÷üÖĆïñúÖøąìï×ĂÜïčĀøĊęêŠĂõćüą×ĂÜēøÙìĊęđðŨî đóČęĂĔĀšñĎšðśü÷ēøÙĀĆüĔÝúšöđĀúüìĊęöĊ ðøąüĆêĉÿĎïïčĀøĊęõć÷Ĕî 1 ðŘÖŠĂîÖćøĕéšøĆïÖćøêøüÝøĆÖþćĒúąøĆïĕüšĔîēøÜó÷ćïćú ĂéĀøČĂ đúĉÖïčĀøĊę üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúøĆÖþćñĎšðśü÷ Heart failure ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Heart failure ìÿĊę ĎïïčĀøĊęìĕéĊę šøĆïÖćøĒîąîĈĔĀšÜéïčĀøĊęøąĀüŠćÜÖćøĂ÷ĎŠ ēøÜó÷ćïćú ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Heart failure ìĊęÿĎïïčĀøĊęìĆĚÜĀöéìĊęøĆïĕüšĔîēøÜó÷ćïćú ĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I50 êĆüĀćø Pdx = I50 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DH0302

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 64 ðøąđõì DH04 Atrial fibrillation ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Atrial fibrillation (AF) øĀĆÿêĆüßĊĚüĆé DH0401 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ AF ĕéšøĆï÷ć Warfarin öĊøąéĆï INR êćöđðŜćĀöć÷ÖćøøĆÖþć ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Atrial fibrillation (AF): Percent of patient received Warfarin within target dose îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Atrial fibrillation Āöć÷ëċÜñĎšðśü÷ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙ Atrial Fibrillation ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚìĊęöćêøüÝêĉéêćö ìĊęĒñîÖñĎšðśü÷îĂÖ ĀøČĂ Warfarin Clinic 2. đðŨîñĎšðśü÷ Atrial fibrillation ìĊęĕöŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï÷ć Warfarin ĔîÖćøøĆÖþć 3. ÙŠć INR øąéĆïđðŜćĀöć÷ Āöć÷ëċÜ ÙŠćĂĆêøćÿŠüî×ĂÜ PT ×ĂÜñĎšðśü÷ Atrial fibrillation êŠĂñĎšðśü÷ðÖêĉĂ÷ĎŠĔîߊüÜ 2-3 êćöđðŜćĀöć÷ÖćøøĆÖþć 4. ñĎšðśü÷ AF ìĊęĕéšøĆï÷ć Warfarin öĊøąéĆïêćöđðŜćĀöć÷ÖćøøĆÖþć Āöć÷ëċÜ ñĎšðśü÷ AF ìĊę ĕéšøĆï÷ć Warfarin ìĊęöĊÙŠć INR øąéĆïđðŜćĀöć÷ĔîìčÖÙøĆĚÜ×ĂÜÖćøêøüÝøĆÖþćĔîĕêøöćÿîĆĚî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤĒúąðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúøĆÖþćñĎšðśü÷ Atrial fibrillation ÿĎêøĔîÖćøÙĈîüè (a/b) x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Atrial fibrillation ìĕöĊę ŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚ ĒúąĕéšøĆï÷ć Warfarin ìĊęöćøĆïÖćøøĆÖþć Ēúą öÙĊŠć INR øąéĆïđðŜćĀöć÷ĔîìčÖÙøĆĚÜ×ĂÜÖćø êøüÝøĆÖþćĔîĕêøöćÿîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Atrial fibrillation ìĕöĊę ŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚ ĒúąĕéšøĆï÷ć Warfarin ìĊęöćøĆïÖćøøĆÖþćìĆĚÜĀöéĔîĕêøöćÿđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I480, I481, I482, I483, I484, I489 êĆüĀćø Pdx = I480, I481, I482, I483, I484, I489 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøöÖćøĒóì÷Ť/ ĂšćÜĂĉÜ 1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report to the American College of cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Call Cardiol 2014; 64: 2246-2280 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2559 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2563 G DH0401

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 65 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę 1 (êčúćÙö 2560): ×÷ć÷Ùüćöîĉ÷ćö “ñĎšðśü÷ AF ìĊęĕéšøĆï÷ć Warfarin öĊ øąéĆïêćöđðŜćĀöć÷ÖćøøĆÖþć Āöć÷ëċÜ ñĎšðśü÷ AF ìĊęĕéšøĆï÷ć Warfarin ìĊęöĊÙŠć INR øąéĆï đðŜćĀöć÷ĔîìčÖÙøĆĚÜ×ĂÜÖćøêøüÝøĆÖþćĔîĕêøöćÿîĆĚî” đóČęĂĔĀšöĊÙüćößĆéđÝîĔîÖćøđÖĘï øüïøüöךĂöĎúđßĉÜðäĉïĆêĉÖćø ðøĆïðøčÜÙøĆĚÜìĊę 2 (êčúćÙö 2563): ðøĆïøĀĆÿēøÙ/øĀĆÿĀĆêëÖćø ĔĀšöĊÙüćöÿĂéÙúšĂÜđðŨî ðŦÝÝčïĆî Āöć÷đĀêč

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 66 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Atrial fibrillation (AF) øĀĆÿêĆüßĊĚüĆé DH0402 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜÖćøđÖĉé adverse event (major bleeding) ×ĂÜñĎšðśü÷ AF ìĊęĕéšøĆï÷ć Warfarin ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Atrial fibrillation (AF): Percent of major bleeding (intracranial hemorrhage and hemorrhage need blood transfusion) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Atrial fibrillation Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙ Atrial Fibrillation ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD9 éĆÜìĊęøąïčĕüšîĊĚìĊęöćêøüÝ êĉéêćöìĊęĒñîÖñĎšðśü÷îĂÖ ĀøČĂ Warfarin Clinic 2. đðŨîñĎšðśü÷ Atrial fibrillation ìĊęĕöŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï÷ć Warfarin ĔîÖćøøĆÖþć 3. ÖćøđÖĉé adverse event Āöć÷ëċÜ major bleeding (intracranial hemorrhage and hemorrhage need blood transfusion) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤĒúąðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúøĆÖþćñĎšðśü÷ Atrial fibrillation ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Atrial fibrillation ìĊęĕöŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï ÷ć Warfarin ìĊęđÖĉé adverse event ĔîĕêøöćÿîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Atrial fibrillation ìĊęĕöŠöĊךĂĀšćöĀøČĂךĂÝĈÖĆé×ĂÜÖćøĔĀš÷ćîĊĚĒúąĕéšøĆï ÷ć Warfarin ĔîÖćøøĆÖþćìĆĚÜĀöé ĔîߊüÜĕêøöćÿđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I480, I481, I482, I483, I484, I489 êĆüĀćø Pdx = I480, I481, I482, I483, I484, I489 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøöÖćøĒóì÷/ Ť ĂšćÜĂĉÜ 1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report to the American College of cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Call Cardiol 2014; 64: 2246-2280 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2559 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2563 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2563): ðøĆïøĀĆÿēøÙ/øĀĆÿĀĆêëÖćø ĔĀšöĊÙüćöÿĂéÙúšĂÜđðŨîðŦÝÝčïĆî Āöć÷đĀêč G DH0402

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 67 Āöüé DN: Neurovascular disease (N) ðøąđõì DN01 Stroke ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Stroke ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stroke: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Stroke Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéÿöĂÜ ēé÷öĊøĀĆÿēøÙĂ÷ĎŠ ĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Stroke Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ Stroke 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷Ĕî ĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷éü÷Öćøđÿ š Ċ÷ßĊüĉê ×ĂÜñĎšðśü÷ Stroke ÝćÖìčÖĀĂñĎšðśü÷Ĕî đéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą ×ĂÜñĎšðśü÷ Stroke ÝćÖìčÖĀĂñĎšðśü÷ĔîߊüÜ đéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I60, I61, I62, I63, I64, I65, I66, I67 êĆüĀćø Pdx = I60, I61, I62, I63, I64, I65, I66, I67 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * UK 8% (ýĎî÷Ť×šĂöĎúøąïïðøąÿćìĄ ÙŠćđÞúĊę÷ךĂöúêĎ ĆĚÜĒêŠÙ.ý. 2010 ĕöŠđÖĉî 7.5%) üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïúéÙŠćđðŜćĀöć÷ÝćÖ 10 đðŨî 8 ĒúąðøĆïđÖèæŤüĆé øąéĆïĄ êćöÙć׊ šĂöĎúÝćÖýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť Āöć÷đĀêč G DN0101

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 68 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0102 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙÿöĂÜ×ćéđúČĂéìĕéĊę šøĆï÷ćêšćîđÖúéđú Ę ČĂé (Antiplatelet) õć÷Ĕî 2 üĆî ĀúĆÜđךćøĆïÖćøøĆÖþćĔîēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Ischemic Stroke: Percent of patient receiving Antiplatelet within 2 days of hospital admission îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ēøÙÿöĂÜ×ćéđúČĂéÝćÖõćüąĀúĂéđúČĂéÿöĂÜêĊïĀøČĂĂčéêĆî (Ischemic stroke) Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙÿöĂÜ×ćéđúČĂé ìĊęöøĀĊ ĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆï÷ćêšćîđÖúĘéđúČĂé Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĕéšøĆïÖćøøĆÖþćéšü÷ÖćøĔĀš Antiplatelet drugs õć÷Ĕî 48 ßĆęüēöÜĀúĆÜđÖĉéĂćÖćø (îĆïøą÷ąđüúćêĆĚÜĒêŠđøĉęööĊĂćÖćø ĒúąđךćøĆïÖćøøĆÖþćĔîēøÜó÷ćïćú ÝîëċÜđüúćìĊęĕéšøĆï÷ć) 3. ñĎšðśü÷ĔîìĊęđךćđÖèæŤÙČĂ ñĎšðśü÷Ăć÷čêĆĚÜĒêŠ 18 ðŘ×ċĚîĕð ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 2-120 üĆî àċęÜĕöŠĂ÷ĎŠĔîÿëćîąðøąÙĆïðøąÙĂÜøą÷ąÿčéìšć÷ ĀøČĂëĎÖÙĆéđúČĂÖđךć ēÙøÜÖćøüĉÝĆ÷ìćÜÙúĉîĉÖ ĀøČĂ Admit đóČęĂìĈÖćøñŠćêĆéĀúĂéđúČĂéĒéÜÙćēøêĉéĒïïĕöŠ đøŠÜéŠüî ĀøČĂĕöŠĔߊñĎšðśü÷ìĊęĕéšøĆï÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂéìćÜĀúĂéđúČĂéõć÷Ĕî 24 ßĆęüēöÜÖŠĂîöćëċÜ ēøÜó÷ćïćú ĀøČĂĕöŠĔߊñĎšðśü÷ìĊęöĊĀúĆÖåćîüŠćöĊđĀêčñúĂĆîÿöÙüøìĊęĕöŠĕéšøĆï ÷ćêšćîđÖúĘéđúČĂéõć÷Ĕî 2 üĆî ĀúĆÜđךćøĆïÖćøøĆÖþćĔîēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Ischemic stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Ischemic Stroke ìĊęĕéšøĆï÷ćêšćîđÖúĘéđúČĂé õć÷Ĕî 48 ßĆęüēöÜĀúĆÜđÖĉé ĂćÖćø ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Ischemic Stroke ìĆĚÜĀöéìøĊę ĆïĕüšĔîēøÜó÷ćïćú ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I63, I64, I65, I66 êĆüĀćø Pdx = I63, I64, I65, I66 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 80 ýĎî÷Ť×šĂöúøąïïðøąÿćì Ď ðŘ2555-2558 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöĀúĂéđúČĂéÿöĂÜĕì÷, ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558) : đóĉęöĒĀúŠÜĂšćÜĂĉÜĒúąìĊęöć ÝćÖýî÷Ď Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť Āöć÷đĀêč G DN0102

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 69 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0103 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúČĂéìĕéĊę øšĆïÖćøÿĆęÜ÷ćêšćîđÖúéđú Ę ČĂé (Antiplatelet) ĀøČĂ÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂé (Anticoagulant) ×èąÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Ischemic Stroke: Percent of Antiplatelet or Anticoagulant therapy prescribed at discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ēøÙĀúĂéđúĂéÿöĂÜ×ćéđú Č ĂéČ (Ischemic stroke) Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ18 ðŘ ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúČĂé ìĊęöĊøĀĆÿēøÙêćö ICD10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆï÷ćêšćîđÖúĘéđúČĂéĀøČĂ÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂé ×èąÝĈĀîŠć÷ĂĂÖÝćÖ ēøÜó÷ćïćú Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĕéšøĆï Antiplatelet or Anticoagulant Drugs ×èą ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ēé÷îĆïđÞóćąÖćøÝĈĀîŠć÷öĊßĊüĉêéšü÷ÿëćîąÖćøĂîčâćêĔĀš ÖúĆïïšćî (improve) 3. ñĎšðśü÷ĔîìĊęđךćđÖèæŤÙČĂ ñĎšðśü÷Ĕî Ăć÷č œ 18 ðŘìĊęøĆïĕüšîĂîĔîēøÜó÷ćïćú îćîĕöŠđÖĉî 120 üĆî àċęÜĕöŠĂ÷ĎŠĔîÖćøðøąÙĆïðøąÙĂÜøą÷ąÿčéìšć÷ĀøČĂëĎÖÙĆéđúČĂÖđךćēÙøÜÖćøüĉÝĆ÷ ĀøČĂ admit đóČęĂìĈÖćøñŠćêĆéĀúĂéđúĂéĒéÜÙćēøê Č ĉéĒïïĕöŠđøŠÜéŠüî ĀøČĂĕöŠĔߊñĎšðśü÷ìĊęöĊĀúĆÖåćî üŠćöĊđĀêčñúĂĆîÿöÙüøìĊęĕöŠĔĀš÷ćêšćîđÖúéđú Ę ĂéĀø Č ČĂ÷ćÖĆîđúĂéđð Č Ũîúĉęö×èąÝĈĀîŠć÷ĂĂÖÝćÖ ēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Ischemic stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Ischemic stroke ìĊęĕéšøïĆ Antithrombotic drugs ×èąÝĈĀîŠć÷ĂĂÖ ÝćÖēøÜó÷ćïćú ĔîߊüÜđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Ischemic stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I63.0, I63.1, I63.2, I63.3, I63.4, I63.5, I63.6, I63.7, I63.8, I63.9 êĆüĀćø Pdx = I63.0, I63.1, I63.2, I63.3, I63.4, I63.5, I63.6, I63.7, I63.8, I63.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 80 ýĎî÷Ť×šĂöúøąïïðøąÿćìð Ď Ř 2555-2558 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöĀúĂéđúČĂéÿöĂÜĕì÷, ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïÙüćößĆéđÝî×ĂÜîĉ÷ćö óøšĂöÖĈĀîéÙŠćđðŜćĀöć÷ĒúąđÖèæŤ üĆéøąéïĄĆ êćöÙŠćךĂöĎúÝćÖýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ćÖøöÖćøĒóì÷Ť Āöć÷đĀêč G DN0103

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 70 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0104 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúČĂéìöĊę ĊõćüąĀĆüĔÝĀšĂÜïîđêîøąø š ĉÖĀøČĂĀĆüĔÝĀšĂÜ ïîđêšîøąøĆüĕéšøĆï÷ćêšćîõćüąĒ×ÜêĘ Ćü×ĂÜđúČĂé (Anticoagulant) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Ischemic Stroke: Percent of patient with Atrial fibrillation/flutter receiving Anticoagulation therapy îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ (Stroke) Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéÿöĂÜ ìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéøšĆï÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂé Āöć÷ëċÜ ÖćøĔĀš Anticoagulant ĔîÖćøøĆÖþćĒÖŠ ñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúĂéì Č ĊęöĊõćüąĀĆüĔÝĀšĂÜïîđêšîøąøĉÖĀøČĂĀĆüĔÝĀšĂÜïîđêšî øąøĆü ìĊęøĆïĕüšîĂîĔîēøÜó÷ćïćú îćîĕöŠđÖĉî 120 üĆî ĕöŠĂ÷ĎŠĔîÖćøðøąÙĆïðøąÙĂÜøą÷ą ÿčéìšć÷ ĀøČĂëĎÖÙĆéđúČĂÖđךćēÙøÜÖćøüĉÝĆ÷ĀøČĂ admit đóČęĂìĈÖćøñŠćêĆéĀúĂéđúČĂéĒéÜÙćēø êĉéĒïïĕöŠđøŠÜéŠüî ĀøČĂĕöŠĔߊñĎšðśü÷ìĊęöĊĀúĆÖåćîüŠćöđĀê Ċ ñúĂ č ĆîÿöÙüøìĊęĕöŠĔĀš÷ćÖĆîđúČĂéđðŨî úĉęö ĒúąĔĀš÷ćĔî×èąÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ēé÷îïđÞóćąÖćøÝĈĀî Ć Šć÷öĊßĊüĉêéšü÷ ÿëćîąÖćøĂîâćêĔĀ č šÖúĆïïšćî (improve) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Stroke ìĊęöõćüą Ċ AF or A-flutter ĒúąĕéšøĆïÖćøïĈïĆééšü÷ Anticoagulant ĔîߊüÜđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Stroke ìĊęöĊõćüą AF or A-flutter ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I63 Sdx = I48, I489 êĆüĀćø Pdx = I63 Sdx = I48, I489 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöĀúĂéđúČĂéÿöĂÜĕì÷, ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2563 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êúćÙö č 2563): ðøïøĀ Ć ÿēøÙ Ć /øĀĆÿĀêëÖćø Ć ĔĀöšĊÙüćöÿĂéÙúšĂÜđðŨîðŦÝÝčïĆî Āöć÷đĀêč G DN0104

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 71 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0105 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÙüćöøĎšĔî×èąĂ÷ĎŠìĊęēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stroke: Percent of patients who were given stroke education during their hospital stay îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ (Stroke) Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéÿöĂÜ ìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆïÙüćöøĎšĀöć÷ëċÜ ÖćøìĊęñĎšðśü÷ēøÙĀúĂéđúĂéÿöĂÜ×ćéđú Č ČĂéĀøČĂēøÙĀúĂéđúĂéČ ÿöĂÜĒêÖ ĀøČĂñĎšéĎĒú ĕéšøĆïÙĈĒîąîĈ/ÙüćöøĎšøąĀüŠćÜĂ÷ēøÜó÷ćïćú ĎŠ ĕéšĒÖŠÖćøĒÝšÜøąïï ÖćøĒóì÷ŤÞčÖđÞĉî ÖćøöćêøüÝêĉéêćöĀúĆÜÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ÷ćìĊęĕéšøĆï×èą ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ðŦÝÝĆ÷đÿĊę÷Ü×ĂÜēøÙĀúĂéđúČĂéÿöĂÜ øüöìĆĚÜĂćÖćøđêČĂî ĒúąĂćÖćø×ĂÜēøÙĀúĂéđúČĂéÿöĂÜ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćúĔîߊüÜđéČĂîîĆĚî ìĊęĕéšøĆïÙüćöøĎš ×èąĂ÷ĎŠĔîēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I60, I61, I62, I63, I64, I65, I66, I67 êĆüĀćø Pdx = I60, I61, I62, I63, I64, I65, I66, I67 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 92 ýĎî÷Ť×šĂöúøąïïðøąÿćì Ď ðŘ 2557 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöĀúĂéđúČĂéÿöĂÜĕì÷, ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïðøčÜîĉ÷ćö “ÖćøĕéšøĆïÙüćöøĎšĕöŠÝĈđðŨîêšĂÜøąïčüŠć ÙøïìĆĚÜ 5 ĀĆüךà đóøćąĂćÝĔĀšĕéÙøĂïÙú š ööćÖÖü č ŠćîĆĚî” ÖĈĀîéÙćđðŠ ŜćĀöć÷ĒúąđÖèæŤĄ êćöýĎî÷Ť×šĂöúøąïïðøąÿćì Ď ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť Āöć÷đĀêč G DN0105

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 72 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0106 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÖćøðøąđöĉîĒúąĕéøšĆïÖćøøĆÖþćéšćîđüßýćÿêøŤ ôŚŪîôĎđóČęĂôîôŚŪ Ďÿöøøëõćóõć÷Ĕî 72 ßĆęüēöÜ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stroke: Percent of treatment, physiotherapy or rehabilitation in stroke or paralytic syndrome within 72 hours îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ (Stroke) Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂéđúČĂéÿöĂÜ ìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøðøąđöĉîéšćîđüßýćÿêøŤôŚŪîôĎđóČęĂôŚŪîôĎÿöøøëõćóĒúąĕéšøĆïÖćøøĆÖþćìćÜđüßýćÿêøŤ ôŚŪîôĎõć÷Ĕî 72 ßĆęüēöÜĀúĆÜøĆïĕüšĔîēøÜó÷ćïćú Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ Stroke àċęÜĕöŠöĊõćüą ìĊęÙčÖÙćößĊüĉêĒúšü ĕéšøĆïÖćøðøąđöĉîéšćîđüßýćÿêøŤôŚŪîôĎĒúąĕéšøĆïÖćøøĆÖþćìćÜđüßýćÿêøŤ ôŚŪîôĎđóČęĂðŜĂÜÖĆîõćüąĒìøÖàšĂî úéÙüćöóĉÖćø ĒúąĔĀšÖúĆïöćߊü÷êĆüđĂÜĕéšöćÖìĊęÿčé õć÷Ĕî 72 ßĆęüēöÜ ĀúĆÜøĆïĕüšĔîēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤÖćøðøąđöĉîĒúąÖćøéĎĒúøĆÖþćó÷ćïćúñðĎš śü÷ Stroke ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷Stroke ìÝĈĀî Ċę Šć÷ĂĂÖÝćÖēøÜó÷ćïćúĒúąÖćøðøąđöĉîéšćîđüßýćÿêøŤôŚŪîôĎđóČęĂ ôŚŪîôĎÿöøøëõćóĒúąĕéšøĆïÖćøøĆÖþćìćÜđüßýćÿêøŤôŚŪîôĎõć÷Ĕî 72 ßĆęüēöÜĀúĆÜøĆïĕüšĔîēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I60, I61, I62, I63, I64, I65, I66, I67 êĆüĀćø Pdx = I60, I61, I62, I63, I64, I65, I66, I67 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 88.8 ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ðŘ 2557 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöĀúĂéđúČĂéÿöĂÜĕì÷, ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2560 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïđóĉęöîĉ÷ćöÖćøðøąđöĉîéšćîđüßýćÿêøŤôŚŪîôõć÷Ĕî Ď 72 ßĆęüēöÜ ĀúĆÜøĆïĕüšĔîēøÜó÷ćïćú ðøĆïðøčÜÙøĆĚÜìĊę2 (êčúćÙö 2560): ðøĆïßČęĂêĆüßĊĚüĆéĔĀšöĊÙüćöÿĂéÙúšĂÜÖĆïîĉ÷ćö ÝćÖđéöĉ “ĂĆêøćñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÖćøðøąđöĉîéšćîđüßýćÿêøôŤ ŚŪîôĎđóČęĂôŚŪîôĎ ÿöøøëõćó” đðŨî “ĂĆêøćñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÖćøðøąđöĉîéšćîđüßýćÿêøŤôŚŪîôĎ đóČęĂôŚŪîôĎÿöøøëõćó ĒúąĕéøšĆïÖćøøĆÖþćìćÜđüßýćÿêøŤôŚŪîôĎõć÷Ĕî 72 ßĆęüēöÜĀúĆÜøĆïĕüš ĔîēøÜó÷ćïćú” êćöךĂđÿîĂ×ĂÜßčößîîĆÖðäĉïĆêĉTHIP Āöć÷đĀêč G DN0106

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 73 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0107 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Stroke éšü÷ēøÙĀúĂéđúČĂéÿöĂÜđéĉö õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stroke: Percent of unplanned re-admission of stroke within 28 days îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Stroke Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂé đúČĂéÿöĂÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Stroke õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Āöć÷ëċÜ ñĎšðśü÷ Stroke ìĊęøĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜÝĈĀîŠć÷ÝćÖēøÜó÷ćïćúõć÷Ĕî 28 üĆî ēé÷ ĕöŠĕéšüćÜĒñî 3. ÖćøÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷öĊßĊüĉêĂĂÖÝćÖ ēøÜó÷ćïćú éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status=improve) ÷ÖđüšîñĎšðśü÷ìĊęĕð øĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ Stroke ìĊęđðŨîñðĎš śü÷Ĕî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Stroke ìĊęêšĂÜøïÖú Ć ĆïđךćēøÜó÷ćïćúéšü÷ēøÙĀúĂéđúČĂéÿöĂÜđéöĉ ēé÷ ĕöŠĕéšüćÜĒñî õć÷Ĕî 28 üĆîĀúĆÜĂĂÖÝćÖēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîđéČĂîÖŠĂîĀîšćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I60, I61, I62, I63, I64, I65, I66, I67 êĆüĀćø Pdx = I60, I61, I62, I63, I64, I65, I66, I67 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 1.4 ýĎî÷Ť×šĂöúøąïïðøąÿćì Ď ðŘ 2557 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïúéÙŠćđðŜćĀöć÷ÝćÖ 10 đðŨî 2 ĒúąðøĆïđÖèæŤüĆé øąéĆïĄ êćöÙć׊ šĂöĎúÝćÖýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť Āöć÷đĀêč G DN0107

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 74 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0109 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćüĆîîĂîđÞúĊę÷×ĂÜñĎšðśü÷ Stroke ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stroke: Average length of stay îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Stroke Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀúĂé đúČĂéÿöĂÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷ Stroke Āöć÷ëċÜ ñúøüö×ĂÜÝĈîüîüĆîîĂîìĊęñĎšðśü÷ Stroke îĂîóĆÖøĆÖþćêĆüĔîēøÜó÷ćïćúēé÷îĆïêĆĚÜĒêŠüĆîìĊęøĆïĕüšÝîëċÜüĆîìĊęÝĈĀîŠć÷ĂĂÖÝćÖ ēøÜó÷ćïćúìčÖøć÷ìĊęÝĈĀîŠć÷ĔîđéČĂîîĆĚî Āćøéšü÷ÝĈîüîñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖ ÝćÖēøÜó÷ćïćúĔîđéČĂîîĆĚî 3. ñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĂĂÖ ÝćÖēøÜó÷ćïćúìčÖÿëćîąÖćøÝĈĀîŠć÷ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøøĆÖþćñðĎš śü÷ēøÙ Stroke ÿĎêøĔîÖćøÙĈîüè a/b ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ñúøüöøą÷ąđüúćüĆîîĂî×ĂÜñĎšðśü÷ Stroke ìčÖøć÷ìĊęÝĈĀîŠć÷ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüî (Ùî) ñĎšðśü÷ Stroke ìĊęÝĈĀîŠć÷ĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I60, I61, I62, I63, I64, I65, I66, I67 êĆüĀćø Pdx = I60, I61, I62, I63, I64, I65, I66, I67 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé üĆî Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * 5.9 üĆî (ÙŠć SD 2.2) ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ðŘ 2557 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆïúéÙŠćđðŜćĀöć÷ÝćÖ 7 đðŨî 6 ĒúąðøĆïđÖèæŤüéĆ øąéĆïĄ êćöÙć׊ šĂöĎúÝćÖýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť ðøĆïðøčÜÙøĆĚÜìĊę2 (êčúćÙö 2564): ðøĆïøć÷úąđĂĊ÷éîĉ÷ćöøą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷ Stroke ĔĀšßĆéđÝî Āöć÷đĀêč G DN0109

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 75 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Stroke øĀĆÿêĆüßĊĚüĆé DN0110 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ Ischemic stroke ìĊęĕéšøĆï Thrombolytic agents õć÷Ĕî 60 îćìĊđöČęĂ öćëċÜēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Ischemic Stroke: Percent of time to thrombolytic administration agents within 60 minutes of arrival îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Ischemic stroke Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙđÿšî đúČĂéĔîÿöĂÜêĊïĀøČĂĂčéêĆî ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ñĎšðśü÷ Ischemic stroke ìĊęĕéšøĆï Thrombolytic agents õć÷Ĕî 60 îćìĊđöČęĂĒøÖøĆï Āöć÷ëċÜ ñĎšðśü÷ìĊęĕöŠöĊךĂĀšćö×ĂÜÖćøĔĀš÷ćîĊĚĒúą ĕéšøĆï Thrombolytic agents ĔîÖćø øĆÖþćõć÷Ĕî 60 îćìĊîĆïêĆĚÜĒêŠøą÷ąđüúćìĊęñĎšðśü÷ĕéšøĆïÖćøêøüÝøĆÖþćìĊę ER/OPD ĒúąøĆï ĕüšĔîēøÜó÷ćïćú ÝîëċÜøą÷ąđüúćìĊęñĎšðśü÷ĕéšøĆï÷ć (door to needle time) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúøĆÖþćñĎšðśü÷ Ischemic stroke ìĊęĕéšøïĆ Thrombolytic agents ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Ischemic stroke ìĊęĕéšøïĆ Thrombolytic agents õć÷Ĕî 60 îćìĊ ĀúĆÜöćëċÜēøÜó÷ćïćúĒêúąÙø Š ĆĚÜ ĔîߊüÜđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Ischemic stroke ìĊęĕéšøĆï Thrombolytic agents ìĊęøĆïđךćøĆÖþćĔî ēøÜó÷ćïćúĔîߊüÜđéČĂîđéĊ÷üÖĆîîîĆĚ øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I63, I64, I65, I66, I67 Ēúą Procedure 99.10 õć÷Ĕî 60 îćìĊ êĆüĀćø Pdx = I63, I64, I65, I66, I67 Ēúą Procedure 99.10 ìĆĚÜĀöé ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * 65% ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïîðøąÿćìü Ć ì÷ć ĉ ÖøöÖćøĒóì÷ŤðŘ2557-2558 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , ýĎî÷Ť×šĂöĎúøąïïðøąÿćì ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷Ť üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ðøĆï definition đðŨî door to needle time ĒúąðøĆï úéÙŠćđðŜćĀöć÷ÝćÖöćÖÖüŠćøšĂ÷úą 95 đðŨîöćÖÖüŠćøšĂ÷úą 65 ēé÷ðøĆïđÖèæŤüĆéøąéĆïĄ êćöÙŠćךĂöúÝćÖý Ď Ďî÷Ť×šĂöúøąïïðøąÿćì Ď ÿëćïĆîðøąÿćìüĉì÷ć ÖøöÖćøĒóì÷ŤĔîðŘ 2557-2558 Āöć÷đĀêč G DN0110

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 76 ðøąđõì DN03 Head injury ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Head injury øĀĆÿêĆüßĊĚüĆé DN0301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ìĊęìĈ Craniotomy ēé÷öĊÿćđĀêčÝćÖÖćø ïćéđÝĘïìĊęýøþą Ċ õć÷Ĕî 28 üĆî ēé÷ĕöĕéŠ šüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Head Injury: Percent of unplanned re-admission of Craniotomy within 28 days îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüéĆ 1. ñĎšðśü÷ìĊęìĈ Craniotomy Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) œ4 ßĆęüēöÜ) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙïćéđÝĘïìĊęýĊøþąàċęÜÝĈđðŨîêšĂÜ ĕéšøĆïÖćøìĈ Craniotomy ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ìĊęìĈ Craniotomy õć÷Ĕî 28 üĆî Āöć÷ëċÜ ñĎšðśü÷ ìĊęìĈ Craniotomy ìĊęøĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜÝĈĀîŠć÷ÝćÖēøÜó÷ćïćúõć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî 3. ÖćøÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Āöć÷ëċÜ ñĎšðśü÷ìĊęìĈ Craniotomy ìĊęÝĈĀîŠć÷öĊßĊüĉê ĂĂÖÝćÖēøÜó÷ćïćú éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status = improve) ÷Öđüšî ñĎšðśü÷ìĊęĕðøĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷Ĕî ìĊęìĈ Craniotomy ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ìĊęìĈ Craniotomy ìĊęêšĂÜøĆïÖúĆïđךćēøÜó÷ćïćúēé÷ĕöŠĕéšüćÜĒñî õć÷Ĕî 28 üĆî ĀúĆÜĂĂÖÝćÖēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîñĎšðśü÷ìĊęìĈ Craniotomy ìĊęÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú ĔîđéČĂîÖŠĂîĀîšćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 01.12, 01.14, 01.20-01.25, 01.31-01.32, 01.39, 01.41, 01.51-01.53, 01.59, 02.01, 02.03-02.06, 02.11-02.12, 02.31-02.35, 02.42, 04.01-04.02, 07.53, 07.61-07.63, 07.65, 07.72, 38.32, 38.61, 38.81, 39.28, 39.51-39.53 êĆüĀćø Procedure = 01.12, 01.14, 01.20-01.25, 01.31-01.32, 01.39, 01.41, 01.51-01.53, 01.59, 02.01, 02.03-02.06, 02.11-02.12, 02.31-02.35, 02.42, 04.01-04.02, 07.53, 07.61-07.63, 07.65, 07.72, 38.32, 38.61, 38.81, 39.28, 39.51-39.53 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DN0301

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 77 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Head injury øĀĆÿêĆüßĊĚüĆé DN0302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊęđÿĊ÷ßĊüĉêõć÷Ĕî 48 ßĆęüēöÜ õć÷ĀúĆÜÖćøïćéđÝĘï (đÞóćąñĎšðśü÷ïćéđÝĘïêŠĂÿöĂÜ) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Head Injury: Percent of mortality within 48 hours îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Head Injury Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî øó. (admit) îćî êĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙ×ĂÜÖćøïćéđÝĘïìĊęýĊøþąàċęÜ đÖĉéÝćÖĒøÜìĊęđךćöćÖøąìïêŠĂýĊøþąĒúąøŠćÜÖć÷ĒúšüÖŠĂĔĀšđÖĉéÙüćöïćéđÝĘïêŠĂĀîĆÜýĊøþą ÖąēĀúÖýĊøþą Ēúą ÿöĂÜ ÖĆïđÿšîðøąÿćìÿöĂÜ (ĂšćÜĂĉÜîĉ÷ćöÝćÖĒîüìćÜÖćø øĆÖþćó÷ćïćúñĎšðśü÷ìćÜýĆú÷Öøøö ēé÷øćßüĉì÷ćúĆ÷ýĆú÷Ēóì÷ŤĒĀŠÜðøąđìýĕì÷ øŠüöÖĆï ÿöćÙöðøąÿćìýĆú÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷) ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. Öćøðśü÷êć÷ÝćÖÖćøïćéđÝĘïìĊęýĊøþą (đÞóćąñĎšðśü÷ïćéđÝĘïêŠĂÿöĂÜ) Āöć÷ëċÜ Öćøêć÷ ÝćÖìčÖÿćđĀêčõć÷Ĕî 48 ßĆęüēöÜ ĀúĆÜÝćÖđÖĉéÖćøïćéđÝĘïìĊęýĊøþą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷Ĕî ēøÙ Head injury ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ïćéđÝĘïìĊęýĊøþą ìĊęÝĈĀîŠć÷éšü÷ÖćøđÿĊ÷ßĊüêĉ õć÷Ĕî 48 ßĆęüēöÜ ĔîߊüÜđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ïćéđÝïìĘ ĊęýĊøþą ìĊęÝĈĀîŠć÷ìčÖÿëćîą ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = S06.0, S06.1, S06.2, S06.3, S06.4, S06.5, S06.6, S06.7, S06.8, S06.9 êĆüĀćø Pdx = S06.0, S06.1, S06.2, S06.3, S06.4, S06.5, S06.6, S06.7, S06.8, S06.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿí., ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DN0302

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 78 ĀöüéêĆüßĊĚüĆé Neurovascular disease ðøąđõìêĆüßĊĚüĆé Head injury øĀĆÿêĆüßĊĚüĆé DN0303 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøñćêŠ ĆéÿöĂÜĔîñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊęöĊIntracranial injury ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Head Injury: Percent of patient underwent craniotomy for Intracranial injury îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Intracranial Injury Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙ×ĂÜÖćø ïćéđÝĘïìĊęýĊøþąßîĉéìĊęöĊÖćøêÖđúĂéĀø Č ĂöČ ĊÙüćöñéðÖê ĉ õć÷ĔîÖąēĀúÖý ĉ Ċøþą ēé÷öĊøĀĆÿēøÙ êćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. Intracranial injury craniotomy Āöć÷ëċÜ ÖćøñŠćêĆéÿöĂÜĔîñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊę öĊÖćøêÖđúČĂéĀøČĂöĊÙüćöñĉéðÖêĉõć÷ĔîÖąēĀúÖýĊøþąàċęÜêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøñŠćêĆé üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷Ĕî ēøÙ Head injury ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêĆéÿöĂÜĔîñĎšðśü÷ïćéđÝĘïìĊęýøþąì Ċ ĊęöĊIntracranial injury Ĕî đéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊęöĊIntracranial injury ĔîߊüÜđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = S06.0, S06.1, S06.2, S06.3, S06.4, S06.5, S06.6, S06.7, S06.8, S06.9 and Procedure = 01.2 or 01.3 êĆüĀćø Pdx = S06.0, S06.1, S06.2, S06.3, S06.4, S06.5, S06.6, S06.7, S06.8, S06.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DN0303

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 79 Āöüé DR: Respiratory disease (R) ðøąđõì DR01 Pneumonia ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé Pneumonia øĀĆÿêĆüßĊĚüĆé DR0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉêĀúĆÜÝćÖđךćøïÖćøø Ć ĆÖþć×ĂÜñĎšðśü÷ēøÙðĂéïüö ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Pneumonia: Percent of mortality after hospital admission îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Pneumonia Āöć÷ëċÜ ñĎšðśü÷ìčÖÖúčŠöĂć÷čàċęÜĂ÷ĎŠĔîÿëćîąñĎšðśü÷Ĕî (ñĎšðśü÷ìęøĊĆïĕüš îĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙðĂéĂĆÖđÿïĀøČĂðĂéïüö ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉêĀúĆÜÝćÖđךćøĆïÖćøøĆÖþć×ĂÜñĎšðśü÷ēøÙðĂéïüö Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖ ìčÖÿćđĀêč×ĂÜñĎšðśü÷ēøÙðĂéïüöìĊęöĊPrincipal Diagnosis (Pdx) êćöìĊęøąïčĕüšĀøČĂñĎšðśü÷ ìĊęöĊēøÙøŠüöĀøČĂēøÙĒìøÖđðŨîēøÙðĂéïüö Ēúą öĊÿćđĀêčÖćøêć÷ÝćÖēøÙēøÙðĂéïüö àċęÜ Ă÷ĎŠĔîÿëćîąñĎšðśü÷Ĕî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷Ĕî ēøÙðĂéïüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜÖćøÝĈĀîŠć÷éšü÷Öćøđÿ÷ßĊ Ċüĉê×ĂÜñĎšðśü÷ēøÙðĂéïüö ÝćÖìčÖĀĂñĎšðśü÷ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą×ĂÜñĎšðśü÷ēøÙðĂéïüö (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx ìĊęđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč ĀøČĂ sdx Ēúą đÿĊ÷ßĊüĉêéšü÷ÿćđĀêčÝćÖēøÙðĂéïüö Pdx or Sdx = J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 êĆüĀćø J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference Australia, ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0101

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 80 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé Pneumonia øĀĆÿêĆüßĊĚüĆé DR0102 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ēøÙðĂéïüöõć÷Ĕî 28 üĆî ēé÷ĕöĕéŠ šüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Pneumonia: Percent of unplanned re-admission within 28 days after last discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Pneumonia Āöć÷ëċÜ ñĎšðśü÷Ĕî Ăć÷č œ 18 ðŘ(ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙðĂé ĂĆÖđÿïĀøČĂðĂéïüö ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ēøÙðĂéïüöõć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ēøÙðĂéïüöìĊęøĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜÝĈĀîŠć÷ÝćÖēøÜó÷ćïćú õć÷Ĕî 28 üĆî éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status=improve) ÷Öđüšî ñĎšðśü÷ìĊęĕð øĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćó×ĂÜÖøąïüîÖćøüćÜĒñîÝĈĀîŠć÷ĒúąÖćøéĎĒúøĆÖþćÖúöñčŠ Ďšðśü÷ðĂé ïüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙðĂéïüöìĊęöÖćøø Ċ ĆïÖúĆïđךćēøÜó÷ćïćúĀúĆÜÝĈĀîŠć÷õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙðĂéïüöìĊęÝĈĀîŠć÷éšü÷ÿëćîąÖćøĂîčâćêĔĀÖúš Ćïïšćî (Status=improve) ĔîđéČĂîÖŠĂîĀîšćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 êĆüĀćø Pdx = J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference Australia, ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïßČęĂêĆüßĊĚüĆé îĉ÷ćö ĒúąÖćøđÖï×Ę šĂöĎú ēé÷đðú÷îÝćÖ Ċę “õć÷Ĕî 28 üĆîĀúĆÜÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú” đðŨî “õć÷Ĕî 28 üĆîēé÷ĕöĕéŠ š üćÜĒñî” àċęÜöĊðøąē÷ßîŤĔîÖćøóĆçîćÙčèõćóöćÖÖüŠć Āöć÷đĀêč G DR0102

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 81 ĀöüéêĆüßĊĚüĆé Respiratory Disease ðøąđõìêĆüßĊĚüĆé Pneumonia øĀĆÿêĆüßĊĚüĆé DR0103 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ēøÙðĂéïüöĕéšøĆïÙĈĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę øąĀüŠćÜĂ÷ĎŠĔîēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Pneumonia: Percent of smoking cessation advice given îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Pneumonia Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙðĂéĂĆÖđÿï ĀøČĂðĂéïüö ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę Āöć÷ëċÜ ÖćøĔĀšÙĈĒîąîĈ/ÖćøðøċÖþć ĔĀšÙüćöøĎšÙüćö đךćĔÝđÖĊę÷üÖĆïñúÖøąìï×ĂÜïčĀøĊęêŠĂõćüą×ĂÜēøÙìĊęđðŨî ĒÖŠñĎšðśü÷ēøÙðĂéïüöìĊęöĊðøąüĆêĉ ÿĎïïčĀøĊęõć÷Ĕî 1 ðŘÖŠĂîĕéšøĆïÖćøêøüÝøĆÖþćĔî×èąĂ÷ĎŠĔîēøÜó÷ćïćú đóČęĂĔĀšñĎšðśü÷ĂéĀøČĂ đúĉÖïčĀøĊę üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷Ĕî ēøÙðĂéïüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙðĂéïüöìĊęÿïïĎ čĀøĊęĕéšøĆïÖćøĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙðĂéïüöìÿĊę ïïĎ čĀøĊęìĆĚÜĀöé (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 êĆüĀćø Pdx = J10.0, J11.0, J12-J16, J17.0*, J17.1*, J17.2*, J17.3*, J17.8*, J18, J85.0, J85.1 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference JCI üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0103

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 82 ðøąđõì DR02 TB (mycobacterium tuberculosis) ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé TB (Mycobacterium tuberculosis) øĀĆÿêĆüßĊĚüĆé DR0201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷üèēøÙðĂéĔîß Ć ŠüÜ 12 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TB: Percent of mortality during 12 months îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷üĆèēøÙðĂé Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙüĆèēøÙðĂé ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷üĆèēøÙðĂéĔîߊüÜ 12 đéČĂî Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč ×ĂÜñĎšðśü÷üĆèēøÙðĂéđÿöĀąóïđßČĚĂøć÷ĔĀöŠ ìĊęĂ÷ĎŠøąĀüŠćÜÖćøøĆÖþćüĆèēøÙ õć÷ĔîߊüÜđüúć 12 đéČĂî×ĂÜÖćøøĆÖþć 3. ñĎšðśü÷üĆèēøÙðĂéđÿöĀąóïđßČĚĂøć÷ĔĀöŠ Āöć÷ëċÜ ñĎšðśü÷ìĊęöĊÖćøêøüÝđÿöĀąĒúąóïđßČĚĂ üĆèēøÙàċęÜđðŨîñĎšðśü÷üĆèēøÙðĂéøą÷ąĒóøŠđßČĚĂøć÷ĔĀöŠìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷üèēøÙðĂé Ć ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéøą÷ąĒóøŠđßČĚĂøć÷ĔĀöŠìĊęđÿĊ÷ßĊüĉêĔîøąĀüŠćÜÖćøøĆÖþćĔîߊüÜ 12 đéČĂî êĆüĀćø b = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéđÿöĀąóïđßČĚĂøć÷ĔĀöŠìĊę×ċĚîìąđïĊ÷îøÖþć Ć (ĔîøĂï ðŘÜïðøąöćèđé÷üÖ Ċ Ćî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = A15, A16 Ēúą đÿĊ÷ßĊüĉêĔîøąĀüŠćÜÖćøøĆÖþćĔîߊüÜ 12 đéČĂî êĆüĀćø Pdx = A15, A16 Ēúą đÿöĀąóïđßČĚĂøć÷ĔĀöŠìĊę×ċĚîìąđïĊ÷îøĆÖþć ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂ ðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ð)Ř ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč ÙĈîĉ÷ćöĒúąüĉíĊÖćøđÖĘïêĆüßĊĚüĆé ĔĀĂš šćÜĂĉÜÝćÖ ÿĈîĆÖüĆèēøÙ ÖøöÙüïÙčöēøÙ G DR0201

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 83 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé TB (Mycobacterium tuberculosis) øĀĆÿêĆüßĊĚüĆé DR0202 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüĊĕéšøĆïÖćøÙĆéÖøĂÜüèēøÙðĂé Ć ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TB: Percentage of people living with HIV having a TB screening îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊĀöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîñĎšðśü÷/ ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñúÖćøêøüÝđúČĂé ÷Čî÷ĆîĒúšüüŠć HIV Positive ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøÙĆéÖøĂÜüĆèēøÙðĂé (Pulmonary TB) Āöć÷ëċÜ ÖćøÖøąìĈĔîךĂĔéךĂĀîċęÜ Ēúą/ ĀøČĂìčÖךà éĆÜîĊĚ (1) ÖćøàĆÖðøąüĆêĉĂćÖćøìćÜÙúĉîĉÖ ĀøČĂÙüćöđÿĊę÷ÜêŠĂÖćøêĉéđßČĚĂüĆèēøÙ đߊî öĊĂćÖćøĕךĕĂ đïČęĂĂćĀćø îĚĈĀîĆÖúéđĀÜČęĂĂĂÖĔîđüúćÖúćÜÙČî êĉéêŠĂÖĆîđÖĉî 2 ÿĆðéćĀŤöĊðøąüĆêĉøĆÖþćüĆèēøÙöćÖŠĂî đÙ÷ĂćýĆ÷ĔÖúšßĉéÖĆïñĎšðśü÷üĆèēøÙöćÖŠĂî đÙ÷öĊ ðøąüĆêĉêšĂÜ×ĆÜöćÖŠĂî đðŨîêšî (2) êøüÝ CXR (3) êøüÝđÿöĀą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąðøąÿĉìíõćóÖøąïüîÖćøêøüÝÙ ĉ ĆéÖøĂÜñðĎš śü÷üĆèēøÙðĂé ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷/ ñêĎšĉéđßČĚĂđĂßĕĂüĊìĊęĕéšøĆïÖćøÙĆéÖøĂÜüèēøÙðĂé Ć Ă÷ŠćÜîšĂ÷ 1 ÙøĆĚÜ Ĕî øĂïðŘÜïðøąöćè êĆüĀćø b = ÝĈîüîñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊĒúąĕöŠĂ÷ĎŠĔîøąĀüŠćÜÖćøøĆÖþćüĆèēøÙ (ĔîøĂï ðŘÜïðøąöćèđé÷üÖ Ċ Ćî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = B20, B21, B22, B23, B24, Z21 êĆüĀćø Pdx = B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂ ðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ð)Ř ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference HIVQUAL-T üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0202

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 84 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé TB (Mycobacterium tuberculosis) øĀĆÿêĆüßĊĚüĆé DR0203 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÙüćöÿĈđøÝÖćøø Ę ĆÖþćüĆèēøÙ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TB: Percent of treatment success îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷üĆèēøÙ Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙüĆèēøÙðĂéēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÙüćöÿĈđøĘÝ×ĂÜÖćøøĆÖþćüĆèēøÙ đðŨîÖćøðøąđöĉîñúÖćøøĆÖþćñĎšðśü÷üĆèēøÙøć÷ĔĀöŠìĊę×ċĚî ìąđïĊ÷îøĆÖþćìčÖøć÷÷šĂîĀúĆÜ 1 ðŘ (12 đéČĂî) àċęÜðøąÖĂïéšü÷ÝĈîüîÖćøøĆÖþćĀć÷ (cure) Ēúą ÝĈîüîÖćøøĆÖþćÙøï (complete) øüöÖĆîđöČęĂđðøĊ÷ïđìĊ÷ïÖĆïÝĈîüîñĎšðśü÷üĆèēøÙóïđßČĚĂøć÷ ĔĀöŠìĊę×ċĚîìąđïĊ÷î 3. ÖćøøĆÖþćĀć÷ (cure) Āöć÷ëċÜ ñĎšðśü÷üĆèēøÙđÿöĀąóïđßČĚĂìĊęĕéšøĆïÖćøøĆÖþćÝîÙøïÖĈĀîé ĒúąĔîøąĀüŠćÜÖćøøĆÖþćöĊñúÖćøêøüÝđÿöĀąđðúĊę÷îđðŨîúï Ă÷ŠćÜîšĂ÷ 2 ÙøĆĚÜ ēé÷đîšîöĊÖćøêøüÝ ÙøĆĚÜÿčéìšć÷đöČęĂÿĉĚîÿčéÖćøøĆÖþćđðúĊę÷îđðŨîúïéšü÷ 4. ÖćøøĆÖþćÙøï (complete) Āöć÷ëċÜ ñĎšðśü÷üĆèēøÙđÿöĀąóïđßČĚĂ ìĊęĕéšøĆïÖćøøĆÖþćÝîÙøï ÖĈĀîé ĔîøąĀüŠćÜÖćøøĆÖþćöĊñúÖćøêøüÝđÿöĀąđðúĊę÷îđðŨîúï ĒêŠĕöŠöĊñúÖćêøüÝÙøĆĚÜÿčéìšć÷ đöČęĂÿĉĚîÿčéÖćøøĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷üèēøÙðĂé Ć ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéóïđßČĚĂøć÷ĔĀöŠìĊęĕéøšĆïÖćøøĆÖþćĀć÷øüöÖĆïÖćøøĆÖþćÙøï êĆüĀćø b = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéóïđ×ČĚĂøć÷ĔĀöŠìĊę×ċĚîìąđïĊ÷îøĆÖþć (ĔîøĂïðŘÜïðøąöćèđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = A15, A16 êĆüĀćø Pdx = A15, A16 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂ ðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ð)Ř ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿí., ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč ÙĈîĉ÷ćöĒúąüĉíĊÖćøđÖĘïêĆüßĊĚüĆé ĔĀĂš šćÜĂĉÜÝćÖ ÿĈîĆÖüĆèēøÙ ÖøöÙüïÙčöēøÙ G DR0203

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 85 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé TB (Mycobacterium tuberculosis) øĀĆÿêĆüßĊĚüĆé DR0204 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷üèēøÙĕé Ć šøĆïÖćøêøüÝÙĆéÖøĂÜ HIV ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TB: Percent of TB having a HIV screening îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷üĆèēøÙ Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙüĆèēøÙðĂéēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ÖćøÙĆéÖøĂÜ HIV Āöć÷ëċÜ ÖćøÙĆéÖøĂÜõćüąÖćøêĉéđßČĚĂđĂßĕĂüĊēé÷ñŠćîøąïï Voluntary counseling and testing (VCT) Ā øČĂðŦÝ ÝčïĆîĂćÝĔßš DCT (diagnosis counseling and testing) PICT (Provider induce counseling and testing) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷üèēøÙðĂé Ć ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéìĕéĊę øšĆïÖćøÙéÖøĂÜ Ć HIV ìĆĚÜēé÷üĉíĊVCT, DCT, PICT êĆüĀćø b = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéìĆĚÜĀöé (ĔîøĂïðŘÜïðøąöćèđéĊ÷üÖîĆ) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = A15, A16 êĆüĀćø Pdx = A15, A16 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂ ðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ð)Ř ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿĈîĆÖüĆèēøÙ ÖøöÙüïÙčöēøÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč ÙĈîĉ÷ćöĒúąüĉíĊÖćøđÖĘïêĆüßĊĚüĆé ĔĀĂš šćÜĂĉÜÝćÖ ÿĈîĆÖüĆèēøÙ ÖøöÙüïÙčöēøÙ G DR0204

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 86 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé TB (Mycobacterium tuberculosis) øĀĆÿêĆüßĊĚüĆé DR0205 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷üèēøÙì Ć ĊęöĊñúđúČĂéđĂßĕĂüĊïüÖĕéšøĆïÖćøøĆÖþćéšü÷ Antiretroviral therapy (ART) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TB: Percent of HIV-positive TB patients started on Antiretroviral therapy (ART) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷üĆèēøÙ Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙüĆèēøÙðĂéēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ñĎšðśü÷ìĊęöĊñúđúČĂéđĂßĕĂüĊïüÖ Āöć÷ëċÜ ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖ ĒúąñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîñĎšðśü÷/ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñú ÖćøêøüÝđúČĂé÷Čî÷ĆîĒúšüüŠć HIV positive ĀøČĂöĊøĀĆÿēøÙĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙ B20-B24, Z21 3. ÖćøøĆÖþćéšü÷ Antiretroviral therapy (ART) Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊ ĕéšøĆïÖćøøĆÖþćēé÷ÖćøÖĉî÷ćêšćîĕüøĆÿÿĎêøĔéÿĎêøĀîċęÜöćîćî öćÖÖüŠć 6 đéČĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷üèēøÙðĂé Ć ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéìĊęöñúđú Ċ ČĂéđĂßĕĂüĊïüÖĕéøšĆïÖćøøĆÖþćéšü÷÷ćêćîĕüø š ÿĆ êĆüĀćø b = ÝĈîüîñĎšðśü÷üĆèēøÙðĂéìĊęöñúđú Ċ ČĂéđĂßĕĂüĊïüÖìĆĚÜĀöé (ĔîøĂïðŘÜïðøąöćè đéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = A15, A16, and B20, B21, B22, B23, B24, Z21 êĆüĀćø Pdx = A15, A16, and B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂ ðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ð)Ř ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿĈîĆÖüĆèēøÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0205

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 87 ž¦³Á£š DR03 Asthma ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé Asthma øĀĆÿêĆüßĊĚüĆé DR0301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Asthma õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Asthma: Percent of unplanned re-admission within 28 days after last discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Asthma Āöć÷ëċÜ ñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀČé ēé÷öĊ øĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïñĎšðśü÷ Asthma ÖúĆïđךćēøÜó÷ćïćú õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ Asthma ÖúĆïöćøĆïÖćøêøüÝøĆÖþćēé÷ĕöŠĕéšüćÜĒñî õć÷ĀúĆÜÝćÖìĊęÝĈĀîŠć÷ ĂĂÖÝćÖēøÜó÷ćïćú éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status=improve) (÷Öđüšî ñĎšðśü÷ìĊęĕðøĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî) õć÷Ĕî 28 üĆî Ēúą êšĂÜøĆïÖúĆïđךćîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ Asthma ìĊęđðŨîñðĎš śü÷Ĕî Ĕîõćóøüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Asthma ìĊęêšĂÜøĆïÖúĆïđךćēøÜó÷ćïćúēé÷ĕöŠĕéšüćÜĒñî õć÷Ĕî 28 üĆî ĀúĆÜĂĂÖÝćÖēøÜó÷ćïćú ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Asthma ìĊęÝĈĀîŠć÷éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî ĔîđéČĂîÖŠĂî ĀîšćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J45, J46 êĆüĀćø Pdx = J45, J46 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I ,ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0301

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 88 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé Asthma øĀĆÿêĆüßĊĚüĆé DR0302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ Asthma ĕéšøĆïÙĈĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę øąĀüŠćÜĂ÷ĎŠĔîēøÜó÷ćïćú ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Asthma: Percent of smoking cessation advice given îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Asthma Āöć÷ëċÜ ñĎšðśü÷Ĕî ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĀČé ēé÷öĊ øĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę Āöć÷ëċÜ ÖćøĔĀšÙĈĒîąîĈ/ÖćøðøċÖþć ĔĀšÙüćöøĎšÙüćö đךćĔÝđÖĊę÷üÖĆïñúÖøąìï×ĂÜïčĀøĊęêŠĂõćüą×ĂÜēøÙìĊęđðŨî ĒÖŠñĎšðśü÷ Asthma ìĊęöĊðøąüêĆĉÿĎï ïčĀøĊęõć÷Ĕî 1 ðŘÖŠĂîÖćøĕéšøĆïÖćøêøüÝøĆÖþćĔî×èąĂ÷ĎŠĔîēøÜó÷ćïćú đóČęĂĔĀšñĎšðśü÷Ăé ĀøČĂđúĉÖïčĀøĊę üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ Asthma ìĊęđðŨîñðĎš śü÷Ĕî Ĕîõćóøüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Asthma ìĊęÿĎïïčĀøĊęĕéšøĆïÖćøĒîąîĈĔĀšĂéĀøČĂđúÖïĉ čĀøĊę êĆüĀćø b = ÝĈîüîñĎšðśü÷ Asthma ìĊęÿĎïïčĀøĊęìĆĚÜĀöé (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J45, J46 êĆüĀćø Pdx = J45, J46 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿí., ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0302

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 89 ðøąđõì DR04 COPD ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé COPD øĀĆÿêĆüßĊĚüĆé DR0401 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ COPD õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) COPD: Percent of unplanned re-admission into the hospital within 28 days after last discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ COPD Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćúîćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal Diagnosis (Pdx) đðŨîēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïñĎšðśü÷ COPD ÖúĆïđךćēøÜó÷ćïćú õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ COPD ÖúĆïöćøĆïÖćøêøüÝøÖþćēé÷ĕö Ć ĕéŠ üćÜĒñî š õć÷ĀúĆÜÝćÖìĊęÝĈĀîŠć÷ĂĂÖ ÝćÖ ēøÜó÷ćïćú éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status = improve) (÷ÖđüšîñĎšðśü÷ ìĊęĕðøĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî) õć÷Ĕî 28 üĆî ĒúąêšĂÜ øĆïÖúĆïđךćîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ COPD ìĊęđðŨîñĎšðśü÷Ĕî Ĕîõćóøüö ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ COPD ìĊęêšĂÜøïÖú Ć ĆïđךćēøÜó÷ćïćúēé÷ĕöĕéŠ šüćÜĒñî õć÷Ĕî 28 üĆî ĀúĆÜĂĂÖÝćÖēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîñĎšðśü÷ COPD ìĊęÝĈĀîŠć÷éšü÷ÿëćîąÖćøĂîâćêĔĀ č šÖúĆïïšćî ĔîđéČĂîÖŠĂîĀîšć îĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J44 êĆüĀćø Pdx = J44 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0401

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 90 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé COPD øĀĆÿêĆüßĊĚüĆé DR0403 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉêÝćÖēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) COPD: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ COPD Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙðĂé ĂčéÖĆĚîđøČĚĂøĆÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ COPD Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ COPD ìĊęöĊ Pdx êćöìĊęøąïčĕüšĀøČĂñĎšðśü÷ìĊęöĊēøÙøŠüöĀøČĂēøÙĒìøÖđðŨî COPD ĒúąöĊÿćđĀêčÖćøêć÷ ÝćÖēøÙ COPD 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷Ĕî ĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą ìčÖÖøèĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ÖćøðøąđöĉîñúúĆóíŤÖćøéĎĒúøĆÖþćñĎšðśü÷ēøÙ COPD ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷éü÷Öćøđÿ š Ċ÷ßĊüĉê×ĂÜñĎšðśü÷ COPD ÝćÖìčÖĀĂñĎšðśü÷ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą×ĂÜñĎšðśü÷ COPD ÝćÖìčÖĀĂñĎšðśü÷ĔîߊüÜđüúć đéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J44 êĆüĀćø Pdx = J44 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0403

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 91 ĀöüéêĆüßĊĚüĆé Respiratory disease ðøąđõìêĆüßĊĚüĆé COPD øĀĆÿêĆüßĊĚüĆé DR0404 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøĂøČĚ ĆÜìĊę÷ĆÜÿĎïïčĀøĊę ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) COPD: Percent of patient with ongoing smoking îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1) ñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜìĊę÷ĆÜÿĎïïčĀøĊę Āöć÷ëċÜ ñĎšðśü÷ìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙðĂéĂčéÖĆĚî đøČĚĂøĆÜìĊę÷ĆÜÿĎïïčĀøĊęĂ÷ĎŠ ĀøČĂ đúĉÖïčĀøĊęêŠĂđîČęĂÜöćđðŨîøą÷ąđüúćĕöŠđÖĉî 12 đéČĂî 2) ñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ Āöć÷ëċÜñĎšðśü÷ìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜìĊęöćøïĆ ÖćøøĆÖþćĒïïñĎšðśü÷îĂÖ×ĂÜēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćó ×ĂÜÖøąïüîÖćøéĎĒúøĆÖþćñðĎš śü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ìĊęöćøĆïïøĉÖćøĒïïñĎšðśü÷îĂÖ×ĂÜēøÜó÷ćïćú ìĊę÷ĆÜ ÿĎïïčĀøĊęĂ÷ĎŠ ĀøČĂ đúĉÖïĀøč ĊęêŠĂđîČęĂÜöćđðŨîøą÷ąđüúćĕöŠđÖĉî 12 đéČĂî (Ùî) êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ìĊęöćøĆïïøĉÖćøĒïïñĎšðśü÷îĂÖ×ĂÜēøÜó÷ćïćú ìĆĚÜĀöé (Ùî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = J44 êĆüĀćø Pdx = J44 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøöÖćøĒóì÷Ť/ ĒîüìćÜđüßðäïĉĆêĉÖćøéĎĒúñðĎš śü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ ðøąđìýĕì÷ ðŘ2558 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2559 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DR0404